Asher Kelman
OPF Owner/Editor-in-Chief
Jérôme,
You are most helpful. Thanks so much.
Asher
You are most helpful. Thanks so much.
Asher
Hello all.
Just to wish all here at OPF and everywhere else, may you and your loved ones all be safe and healthy.
I am not a medical person nor a scientist...but making has gotten through many a pandemics. Some with horrific losses. But we got through!
My family and my prayers for all that we get through this pandemic with minimal life losses. And maybe start to practice a little humility towards each other and the planet we all share.
Amen.
1. Trial with Chroroquine, Hydroxychloroquine and Azithromycin will start next Tuesday in New York!
If they include enough people, I predict preliminary results in less than 30 days:
It could be spectacular!
It will change the mood of the Nation overnight!
The first results are not so good: https://www.military.com/daily-news...s-no-benefit-malaria-drug-va-virus-study.html
A malaria drug widely touted by President Donald Trump for treating the new coronavirus showed no benefit in a large analysis of its use in U.S. veterans hospitals. There were more deaths among those given hydroxychloroquine versus standard care, researchers reported.
Disappointing. Still it might be that the drug might play a role in pointing to the virus machinery targets to be better tackled by other agents.In one of the largest study of its kind, hydroxychloroquine was not found to improve outcomes for in-hospital patients: https://jamanetwork.com/journals/jama/fullarticle/2766117
Disappointing. Still it might be that the drug might play a role in pointing to the virus machinery targets to be better tackled by other agents.
On the molecular level, it’s effective, but not as used clinically in desperately ill patients.Or it could simply mean that the drug is not effective against the virus and has serious side effects at the doses used for the trial.